The non-mRNA COVID-19 vaccines that targeted the entire virus rather than just the spike protein generally produced somewhat more durable immunity even after many mutations. In principle it might be possible to make mRNA vaccines that work in a similar way, so I don't think it's a fundamental weakness in the technology.